KAM
ABBV icon

Knightsbridge Asset Management’s AbbVie ABBV Stock Holding History

Knightsbridge Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
4,023
+16
+0.4% +$3.44K 0.13% 85
2026
Q1 		$871K Buy
4,007
+99
+3% +$22K 0.12% 92
2025
Q4 		$893K Buy
3,908
+234
+6% +$53.3K 0.14% 77
2025
Q3 		$851K Buy
3,674
+867
+31% +$177K 0.14% 73
2025
Q2 		$521K Buy
2,807
+997
+55% +$185K 0.11% 86
2025
Q1 		$379K Buy
1,810
+656
+57% +$128K 0.1% 97
2024
Q4 		$205K Buy
+1,154
New +$212K 0.05% 114

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Knightsbridge Asset Management's ABBV Position: Q2 2026 in Review

Knightsbridge Asset Management increased its AbbVie (ABBV) stake by 0.4% in Q2 2026, buying an estimated $3.44K and bringing the position to 4,023 shares worth $1.01M. The position accounts for 0.13% of the portfolio, ranked #85.

Knightsbridge Asset Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Knightsbridge Asset Management held 4,023 shares of AbbVie worth $1.01M as of Q2 2026.
  • Knightsbridge Asset Management bought 16 AbbVie shares in Q2 2026, an estimated $3.44K.
  • AbbVie made up 0.13% of Knightsbridge Asset Management's portfolio in Q2 2026, its #85 holding.
  • Knightsbridge Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Knightsbridge Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.